Logo image of BSAC

BANCO SANTANDER-CHILE-ADR (BSAC) Stock Fundamental Analysis

NYSE:BSAC - US05965X1090 - ADR

23.97 USD
+0.26 (+1.1%)
Last: 8/28/2025, 5:59:16 PM
23.97 USD
0 (0%)
After Hours: 8/28/2025, 5:59:16 PM
Fundamental Rating

3

BSAC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 393 industry peers in the Banks industry. BSAC has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, BSAC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

Each year in the past 5 years BSAC has been profitable.
In multiple years BSAC reported negative operating cash flow during the last 5 years.
BSAC Yearly Net Income VS EBIT VS OCF VS FCFBSAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B -500B 1T 1.5T

1.2 Ratios

With an excellent Return On Assets value of 1.62%, BSAC belongs to the best of the industry, outperforming 91.86% of the companies in the same industry.
Looking at the Return On Equity, with a value of 23.70%, BSAC belongs to the top of the industry, outperforming 99.24% of the companies in the same industry.
Industry RankSector Rank
ROA 1.62%
ROE 23.7%
ROIC N/A
ROA(3y)1.05%
ROA(5y)1.06%
ROE(3y)16.98%
ROE(5y)17.65%
ROIC(3y)N/A
ROIC(5y)N/A
BSAC Yearly ROA, ROE, ROICBSAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

BSAC has a Profit Margin of 31.47%. This is amongst the best in the industry. BSAC outperforms 84.22% of its industry peers.
In the last couple of years the Profit Margin of BSAC has grown nicely.
BSAC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 31.47%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.43%
PM growth 5Y3.1%
GM growth 3YN/A
GM growth 5YN/A
BSAC Yearly Profit, Operating, Gross MarginsBSAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

BSAC has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BSAC has about the same amount of shares outstanding.
The debt/assets ratio for BSAC has been reduced compared to a year ago.
BSAC Yearly Shares OutstandingBSAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
BSAC Yearly Total Debt VS Total AssetsBSAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20T 40T 60T

2.2 Solvency

The Debt to FCF ratio of BSAC is 10.55, which is on the high side as it means it would take BSAC, 10.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.55, BSAC is doing worse than 78.37% of the companies in the same industry.
BSAC has a Debt/Equity ratio of 2.57. This is a high value indicating a heavy dependency on external financing.
BSAC has a Debt to Equity ratio of 2.57. This is amonst the worse of the industry: BSAC underperforms 91.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 10.55
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
BSAC Yearly LT Debt VS Equity VS FCFBSAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5T 10T

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BSAC Yearly Current Assets VS Current LiabilitesBSAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2T 4T 6T 8T 10T

More info and screens

5

3. Growth

3.1 Past

BSAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.87%, which is quite impressive.
BSAC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.13% yearly.
Looking at the last year, BSAC shows a very strong growth in Revenue. The Revenue has grown by 22.99%.
BSAC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.93% yearly.
EPS 1Y (TTM)84.87%
EPS 3Y3.53%
EPS 5Y9.13%
EPS Q2Q%20.69%
Revenue 1Y (TTM)22.99%
Revenue growth 3Y6.01%
Revenue growth 5Y5.93%
Sales Q2Q%12.59%

3.2 Future

BSAC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.08% yearly.
Based on estimates for the next years, BSAC will show a small growth in Revenue. The Revenue will grow by 4.82% on average per year.
EPS Next Y22.8%
EPS Next 2Y12.88%
EPS Next 3Y10.79%
EPS Next 5Y4.08%
Revenue Next Year12.39%
Revenue Next 2Y8.79%
Revenue Next 3Y8.13%
Revenue Next 5Y4.82%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BSAC Yearly Revenue VS EstimatesBSAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1T 2T 3T
BSAC Yearly EPS VS EstimatesBSAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500 1K 1.5K 2K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
BSAC Price Earnings VS Forward Price EarningsBSAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BSAC Per share dataBSAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.88%
EPS Next 3Y10.79%

More info and screens

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.26%, BSAC is a good candidate for dividend investing.
BSAC's Dividend Yield is rather good when compared to the industry average which is at 3.30. BSAC pays more dividend than 81.17% of the companies in the same industry.
BSAC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 4.26%

5.2 History

The dividend of BSAC decreases each year by -0.44%.
BSAC has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BSAC decreased recently.
Dividend Growth(5Y)-0.44%
Div Incr Years1
Div Non Decr Years1
BSAC Yearly Dividends per shareBSAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

BSAC pays out 56.11% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP56.11%
EPS Next 2Y12.88%
EPS Next 3Y10.79%
BSAC Yearly Income VS Free CF VS DividendBSAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500B -500B 1T 1.5T
BSAC Dividend Payout.BSAC Dividend Payout, showing the Payout Ratio.BSAC Dividend Payout.PayoutRetained Earnings

More info and screens

BANCO SANTANDER-CHILE-ADR

NYSE:BSAC (8/28/2025, 5:59:16 PM)

After market: 23.97 0 (0%)

23.97

+0.26 (+1.1%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners19.28%
Inst Owner Change-4.26%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.29B
Analysts72.86
Price Target24.14 (0.71%)
Short Float %0.28%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield 4.26%
Yearly DividendN/A
Dividend Growth(5Y)-0.44%
DP56.11%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-23 2025-04-23 (1.329458)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.48%
Min EPS beat(2)0.85%
Max EPS beat(2)2.11%
EPS beat(4)4
Avg EPS beat(4)6.13%
Min EPS beat(4)0.85%
Max EPS beat(4)11.91%
EPS beat(8)4
Avg EPS beat(8)-7.97%
EPS beat(12)5
Avg EPS beat(12)-7.55%
EPS beat(16)9
Avg EPS beat(16)-2%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)-0.49%
Revenue beat(4)2
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-2.21%
Max Revenue beat(4)2.97%
Revenue beat(8)3
Avg Revenue beat(8)-3.12%
Revenue beat(12)5
Avg Revenue beat(12)-0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.47%
PT rev (3m)-2.92%
EPS NQ rev (1m)4.39%
EPS NQ rev (3m)0.87%
EPS NY rev (1m)6.24%
EPS NY rev (3m)6.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.71%
Revenue NY rev (1m)1.23%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.62%
ROE 23.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 31.47%
GM N/A
FCFM 48.26%
ROA(3y)1.05%
ROA(5y)1.06%
ROE(3y)16.98%
ROE(5y)17.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.43%
PM growth 5Y3.1%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.57
Debt/FCF 10.55
Debt/EBITDA N/A
Cap/Depr 65.9%
Cap/Sales 2.68%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 153.35%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)70.12%
Cap/Depr(5y)67.23%
Cap/Sales(3y)3.66%
Cap/Sales(5y)3.4%
Profit Quality(3y)98.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.87%
EPS 3Y3.53%
EPS 5Y9.13%
EPS Q2Q%20.69%
EPS Next Y22.8%
EPS Next 2Y12.88%
EPS Next 3Y10.79%
EPS Next 5Y4.08%
Revenue 1Y (TTM)22.99%
Revenue growth 3Y6.01%
Revenue growth 5Y5.93%
Sales Q2Q%12.59%
Revenue Next Year12.39%
Revenue Next 2Y8.79%
Revenue Next 3Y8.13%
Revenue Next 5Y4.82%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-49.86%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1833.88%
FCF growth 3YN/A
FCF growth 5Y-11.63%
OCF growth 1Y812.46%
OCF growth 3YN/A
OCF growth 5Y-10.82%